Research Article
Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study
Table 4
Adverse effects in UDCA and non-UDCA (
(%)).
| | UDCA () | Non-UDCA () | Univariate analysis | Multivariate analysis | | OR | 95% CI | value | aOR | 95% CI | value |
| | Preeclampsia | 6 (8.22) | 6 (14.63) | 0.52 | 0.16-1.74 | 0.29 | — | — | — | | Cesarean section | 22 (30.14) | 18 (43.90) | 0.56 | 0.25-1.25 | 0.16 | — | — | — | | Preterm birth | 1 (1.37) | 6 (14.63) | 0.08 | 0.01-0.70 | 0.02 | 0.10 | 0.01-0.90 | 0.04 |
|
|
ICP—patients whose bile acids are above 10 μmol/l. ICP: intrahepatic cholestasis of pregnancy.
|
